Interchange Capital Partners, LLC Exact Sciences Corp Transaction History

Interchange Capital Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$62.68 - $95.05 $53,278 - $80,792	-850 Reduced 21.46%	3,110 $292,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $38,507 - $57,748	-816 Reduced 17.09%	3,960 $268,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $128,866 - $225,674	-4,246 Reduced 47.06%	4,776 $236,000
Q3 2022 Nov 07, 2022	SELL	$31.97 - $49.37 $20,684 - $31,942	-647 Reduced 6.69%	9,022 $293,000
Q2 2022 Aug 05, 2022	SELL	$35.61 - $76.23 $15,205 - $32,550	-427 Reduced 4.23%	9,669 $380,000
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $196,452 - $281,709	3,413 Added 51.07%	10,096 $705,000
Q4 2021 Feb 04, 2022	BUY	$72.5 - $100.68 $484,517 - $672,844	6,683 New	6,683 $520,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $487,500 - $724,900	-5,205 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$116.57 - $155.01 $40,100 - $53,323	344 Added 7.08%	5,205 $752,000
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $484,204 - $690,845	4,861 New	4,861 $644,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Interchange Capital Partners, LLC with notifications on news.